celeberating 10年保护

让您的免疫操作更简单

不受母源抗体的干扰，也不需要计算接种日期；只需在孵化场1日龄精确免疫。梅里亚优质的接种设备及行业领先的技术服务使您的鸡群的免疫接种从此高枕无忧。

了解更多

您没看到的，可能已经损害了您的收益

亚临床型传染性法氏囊病虽然没有明显的临床症状，但仍可以导致严重的免疫 抑制和生产性能低下 5，16-17。研究结果证实，VAXXITEK® HVT+IBD疫苗能够通过预防传染性法氏囊病和鸡马立克氏病，避免免疫抑制，从而为鸡群奠定坚实的免疫基础5-8，13-15，31。

了解更多

通过降低胴体废弃率每年大约节省17.5万美金

巴西的一项研究表明，接种VAXXITEK® HVT+IBD疫苗很好的预防了肉鸡的传染性法氏囊病和鸡马立克氏病，减少疾病发生风险，降低胴体废弃率，大大降低了加工厂的单位成本4。

了解更多

VAXXITEK® HVT + IBD

创新的载体疫苗是梅里亚对家禽行业的一大贡献

无论肉鸡、蛋鸡还是种鸡，只需孵化场一针，即可提供对传染性法氏囊病和鸡马立克氏病两大免疫抑制性疾病的免疫保护。

创新，让我们与众不同。

 

独特的解决方案，全面保护您的鸡群

VAXXITEK® HVT+IBD解决方案：迄今已发表了超过65篇的科学论文证明VAXXITEK® HVT+IBD能够提供对鸡马立克氏病和传染性法氏囊病的免疫保护，（查看所有文献 ）且不论是对经典型、变异型及超强毒型的传染性法氏囊病病毒引起的法氏囊病都能提供临床保护。 此外，梅里亚为客户定制个性化服务来整合优化免疫程序。

鸡群今天的健康、是您明天收益的保证

通过接种VAXXITEK® HVT+IBD疫苗，预防传染性法氏囊病和鸡马立克氏病，使鸡群生产的多个关键参数指标得到改善。经研究和客户证实：低患病风险的鸡群，同时在增重 1-3、饲料转化率 1，3、均匀度 1，3等方面都有很好的表现。

了解更多
71589995057

鸟类的数十亿美元。

数据统计：VAXXITEK® HVT+IBD疫苗惠及全球数十亿家禽，2006年首先在巴西上市以来，至今已在全世界75个国家和地区上市销售。

75+

在超过75个国家注册，主要的生产基地：

美国盖恩斯维尔
法国里昂
中国南昌
*以商品名VAXXITEK HVT+IBD的疫苗产品在全世界范围内销售

1

只需孵化场一针

在孵化场胚内注射（孵化到18-19天） 在健康鸡雏1日龄鸡皮下注射1次

2

有效的保护

已证实能够保护两种免疫 抑制性疾病：马立克氏病和IBD

3

肉鸡、蛋鸡与种鸡

对肉鸡、蛋鸡、种鸡三种 类型都能够提供保护*

以梅里亚优质的技术服务和支持为依托，为您鸡群建立起安全、坚实的免疫基础5-8, 13-15, 31

了解更多
数十亿家禽，同一个解决方案
世界各地的Vaxxitek
为什么选择VAXXITEK® HVT+IBD?

我们如何才能帮助你？

不仅仅是提供产品：更是建立一种合作关系、优化程序、提供工具和各种资源，帮助您获得最大的潜能。

VAXXITEK® HVT+IBD的整体解决方案

以优质互信的合作伙伴关系为依托，为客户定制现场服务，使鸡群免受传染性法氏囊病和鸡马立克氏病的困扰。

了解更多

科学文献

以全世界权威的研究文献和试验结果来验证和检验我们的选择，用一系列指标和案例来评估VAXXITEK® HVT+IBD的使用效果。

了解更多

加入我们的在线学习社区

加入我们的在线互动模块，获得更多关于VAXXITEK HVT + IBD及家禽业的其他信息

了解更多

告诉我们您的需求…

想了解更多VAXXITEK® HVT+IBD的信息？经营策略？行业展望？请提出您的问题，让我们深入探讨。

了解更多
“使用VAXXITEK HVT + IBD，帮助公司每公斤肉节省了7分钱”
Dr. Alberto BoteroAvidesa MacPollo, Colombia

客户观点：VAXXITEK® HVT + IBD预防鸡传染性法氏囊病和马立克氏病，减少疾病困扰，通过三个生产参数的改善而提高生产性能。1-4, 7-8
“VAXXITEK HVT + IBD使用组体重增大，存活率提高了，法氏囊病的大小也更加理想。”
Chong Tau Yeng Gesing Group Sdn Bhd, 马来西亚

客户观点：VAXXITEK® HVT + IBD预防鸡传染性法氏囊病和马立克氏病，减少疾病困扰，通过三个生产参数的改善而提高生产性能。1-4, 7-8
“VAXXITEK HVT + IBD是我们获得更好的饲料转化率的一个非常重要因素，减少饲料消耗而获得更大的产肉量”
Dr. Irineu Dantes PeronCopacol, 巴西

客户观点：VAXXITEK® HVT + IBD预防鸡传染性法氏囊病和马立克氏病，减少疾病困扰，通过三个生产参数的改善而提高生产性能。1-4, 7-8
“好消息是：节省了免疫时间，我可以早点回家。没有VAXXITEK® HVT+IBD 是个坏消息，这是退步。”
Christian Chatard生产者，“Bresse”标签鸡 法国

客户观点：VAXXITEK® HVT + IBD预防鸡传染性法氏囊病和马立克氏病，减少疾病困扰，通过三个生产参数的改善而提高生产性能。1-4, 7-8
“生产指标（欧指）大大提高——约15～20个点”
József Palágyi 匈牙利

客户观点：VAXXITEK® HVT + IBD预防鸡传染性法氏囊病和马立克氏病，减少疾病困扰，通过三个生产参数的改善而提高生产性能。1-4, 7-8
“取得了令人惊叹的结果，公司扩大了VAXXITEK® HVT+IBD疫苗的使用，过去4年，我们共使用了3亿多羽份” 李文迹 福建圣农集团副董事长&首席兽医师
Li Wen Ji
福建圣农集团副董事长&首席兽医 中国

客户观点：VAXXITEK® HVT + IBD预防鸡传染性法氏囊病和马立克氏病，减少疾病困扰，通过三个生产参数的改善而提高生产性能。1-4, 7-8

The views expressed are of the customer. VAXXITEK® HVT + IBD is indicated to aid in the prevention of Marek’s and infectious bursal diseases; it may help poultry businesses improve productivity because flocks with lower disease burden often perform better across key production parameters.

更多客户推荐

参考文献

查看所有

1. Fernandez R, Rojo F, Garcia H, Sanchez P, Martinez H, Menendez A, Ruiz H et al. Field efficacy in broiler chickens in Latin America of vHVT-013, a Marek’s HVT vector vaccine expressing VP2 in infectious bursal disease virus. Oral presentation and abstract at the 15th congress of the World Veterinary Poultry Association, 2007; p199.

2. Atienza JC, Nagera AJ, Martinez PO, Baysac ND, Castillo MT, Damaso VR, Lemière S. Evaluation of a herpesvirus of turkey vector vaccine inducing protection against infectious bursal and Marek’s diseases (VAXXITEK® HVT+IBD) under Philippines field conditions. Oral presentation. XXIII World Poultry Congress, Brisbane, Australia. 2008. Article wpc0801684, 9 p.

3. Garritty AT. The eff ect of vectored HVT+IBD (Vaxxitek® HVT + IBD) vaccination on body weights, uniformity and virus shedding in commercial broilers. Abstract. International Poultry Scientifi c Forum, Atlanta, 2011; p31.

4. Godinho E, Pereira CJ, Fernandez A, Lemiere S. Case study of broiler chicken carcass condemnation in Brazil – Improved control using a herpesvirus turkey-infectious bursal disease (HVT-IBD) vector vaccine. Oral presentation. XVIIth Congress of the World Veterinary Poultry Association, Cancun, Mexico, 2011.

5. Hoerr FJ. Clinical Aspects of Immunosuppression in Poultry. Avian Dis., 2010; 54:2-15.

6. Naqi S, Thompson G, Bauman B, Mohammed H. The Exacerbating Effect of Infectious Bronchitis Virus Infection on the Infectious Bursal Disease Virus-Induced Suppression of Opsonization by Escherichia coli Antibody in Chickens. Avian Dis., 2001; 45:52-60.

7. Alonso Castro M, Merino Cabria D, Fernandez Garcia D, Torrubia Diaz J, Herreras Viejo R, Fernandez Revuelta J, Mateo Oyague J, Carvajal Uruena A. Evaluation of the effects of vaccination with a HVT-IBD vector vaccine on bursa Fabricii, production parameters and meat properties in broilers. Abstract. XVIIIth Congress of the World Veterinary Poultry Association, Nantes, France, 2013; in-press.

8. Devaud I, Herin JB, Trotel A, Pagot E, Voisin F. A field study in commercial layers to evaluate the effects of an HVT-IBD vector vaccine on production performances in comparison with a live IBD vaccine. Abstract. XVIIIth Congress of the World Veterinary Poultry Association, Nantes, France, 2013; in-press.

9. Lemiere S, Gauthier J.C., Kodjo A., Vinit L., Delvecchio A., Prandini F. Evaluation of the Protection against Infectious Bursal Disease (IBD) Challenge in Progeny Born to Parents Having Received a Vaccination Program Using Herpesvirus of Turkey-Infectious Bursal Disease (HVT-IBD) Vector Vaccine. World J. Vaccines, 2013; 3:46-51.

10. Goutebroze S, Curet M, Jay ML, Roux C, Le Gros F-X. Efficacy of a recombinant vaccine HVT-VP2 against Gumboro disease in the presence of maternal antibodies. British Poultry Science, 2003;44:824-825.

11. Massi P, Tosi G, Fiorentini L. Experimental challenge trial with a «very virulent» strain of Infectious Bursal Disease virus (vvIBDV) in commercial pullets vaccinated with an IBD vectored vaccine or with three different modified live vaccines. Zootecnica International, November 2008;50-57.

12. Bublot M, Pritchard N, Le Gros F-X, Goutebroze S. Use of a vectored vaccine against infectious bursal disease of chickens in the face of high-titred maternally derived antibody. Journal of Comparative Pathology, 2007;137:81-84.

13. Ganapathy K, Wilkins M, Forrester A, Jones RC, Lemiere S. Protection and immune responses against virulent infectious bronchitis viruses in HVT-IBD recombinant or IBD-complex vaccinated broiler chicks. Abstract. 1st International Respiratory Disease Conference, Athens, United States of America, 2011; p15.

14. Lemiere S, Wilkins M, Forrester A, Jones R, Ganapathy K. Protection and immune responses against virulent infectious bronchitis (IB) viruses in herpesvirus turkey-infectious bursal disease (HVT-IBD) vaccinated broiler chicks. Poster presentation. XVIIth Congress of the World Veterinary Poultry Association, Cancun, Mexico, 2011.

15. Rautenschlein S, Lemiere S, Prandini F. Evaluation of the effects of an HVT-IBD vector vaccine on the immune system of layer pullets in comparison with two commercial live IBD vaccines. Abstract. XVIIIth Congress of the World Veterinary Poultry Association, Nantes, France, 2013; in-press.

16. Rosenberger JK, Cloud SS. Identification and characterization of variant infectious bursal disease variant viruses. Journal of American Veterinary Medicine Association, 1986;189:357.

17. Cheville NF. Studies on the pathogenesis of Gumboro disease in the bursa of Fabricius, spleen and thymus of the chicken. American Journal of Pathology, 1967;51:527-551.

18. Le Gros F-X, Dancer A, Giacomini C, Pizzoni L, Bublot M, Graziani M, Prandini F. Field efficacy trial of a novel HVT-IBD vector vaccine for 1 day-old broilers. Vaccine, 2009;27:592-596.

19. Prandini F, Bublot M, Le Gros F-X, Dancer A, Pizzoni L, Lamichhane C. Assessment of the immune response in broilers and pullets using two ELISA lits after in ovo or day-old vaccination with a vectored HVT+IBD vaccine (VAXXITEK HVT+IBD). Zootecnica International, September 2008;40-50.

20. Lemiere S, Wong YS, Saint-Gerand AL, Goutebroze S, le Gros FX. Compatibility of Turkey Herpesvirus–Infectious Bursal Disease Vector Vaccine with Marek’s Disease Rispens Vaccine Injected into Day-Old Pullets. Avian Dis., 2011; 55:113-118.

21. Richard-Mazet A, Goutebroze S, Duboeuf M, Le Gros FX, Lemiere S, Bublot M. Compatibility of fowlpox-avian influenza and herpesvirus of turkey-infectious bursal disease vector vaccines injected in ovo to embryonated chicken eggs. Article. XVIIth Congress of the World Veterinary Poultry Association, Cancun, Mexico, 2011; p852-857.

22. Jay ML, Bizzini S, Duboeuf M, Goutebroze S, Le-Gros FX. Compatibility of a novel vector vaccine HVT-Gumboro with Newcastle and infectious bronchitis vaccination at one day of age. Abstract. 16th congress of the World Veterinary Poultry Association, Marrakesh, Morocco, 2009; p341.

23. Lemiere S, Fernandez R, Pritchard N, Cruz-Coy J, Rojo F, Wong SY, Saint-Gerand AL, Gauthier JC, Perozo F. Concomitant Turkey Herpesvirus–Infectious Bursal Disease Vector Vaccine and Oil-Adjuvanted Inactivated Newcastle Disease Vaccine Administration: Consequences Compatibility of Turkey Herpesvirus–Infectious Bursal Disease. Avian Dis., 2011; 55:642-649.

24. Botero LA, Fernandez R, Rojo F, Orrego JC, Lemiere S. Colombian chicken meat industry performance further to the use of VAXXITEK HVT+IBD vector vaccine. Oral presentation. 16th congress of the World Veterinary Poultry Association, Marrakesh, Morocco, 2009; p169.

25. Körösi L, Povazsan J, Penzes L, Sari I. Field results of VAXXITEK HVT+IBD vaccination in coloured birds in Hungary. Poster. 16th congress of the World Veterinary Poultry Association, Marrakesh, Morocco, 2009; p339.

26. Tang SF, He SJ, Li WM, Lemiere S. Field experience of vaccination in day-old broiler chickens with a herpesvirus turkey-infectious bursal disease (HVT-IBD) vector vaccine in different systems of chicken production across China. Poster presentation. XVIIth Congress of the World Veterinary Poultry Association, Cancun, Mexico, 2011; p920-926.

27. Herrmann A, Negm H, Sultan H. Turkey herpesvirus infectious bursal disease (HVT-IBD) vector vaccine – Field experience in commercial broilers in Egypt. Article. XVIIth Congress of the World Veterinary Poultry Association, Cancun, Mexico, 2011; p556-563.

28. Ochoa R. Monitoring of safety and efficacy of a herpesvirus turkey-infectious bursal disease (HVT-IBD) in a commercial layer operation in Mexico. Article. XVIIth Congress of the World Veterinary Poultry Association, Cancun, Mexico, 2011; p770-774.

29. Korosi L, Povazsan J, Sari I, Penzes L. Comparative field study of the Vaxxitek® HVT-IBD vaccine in commercial layer flocks. Article. XVIIth Congress of the World Veterinary Poultry Association, Cancun, Mexico, 2011; p644-650.

30. Lemiere S, Rojo R, He S, Tang S, Li W, Herrmann A, Prandini F. Benefits of the Herpesvirus of Turkey vector vaccine of Infectious Bursal Disease in control of immune-depression in broilers and decrease of use of antibiotic medication. Abstract. XVIIIth Congress of the World Veterinary Poultry Association, Nantes, France, 2013; in-press.

31. Rautenschlein S, Lemiere S, Simon B, Prandini F. A comparison of the effects on the humoral and cell-mediated immunity between an HVT-IBD vector vaccine and an IBDV immune complex vaccine after in ovo vaccination of commercial broilers. Article. XVIIth Congress of the World Vet.

32. Lemiere S, Bublot M, de Saint-Vis B, Le-Gros FX, Dancer A, Bollart A, Carlotti A. Validation of VAXXITEK HVT+IBD vaccine intake in chickens using vHVT13-specifi c qPCR by processing different tissue samples. Oral presentation. 16th congress of the World Veterinary Poultry Association, Marrakesh, Morocco, 2009; p165.

33. Rautenschlein S, Simon B, Jung A, Pöppel M, Prandini F, Lemiere S. Protective efficacy of VAXXITEK HVT + IBD in commercial layers and broilers against challenge with very virulent infectious bursal disease virus. 16th congress of the World Veterinary Poultry Association, Marrakesh, Morocco, 2009.

联系我们

梅里亚家禽通讯

注册后，您将定期接收有关VAXXITEK® HVT+IBD以及其他相关产品的交流信息，包括免费的期刊通讯等。